About ESMO Symposium on Signalling Pathways in Cancer 2019

The 7th edition of the ESMO Symposium on Signalling Pathways in Cancer, in partnership with the European Association for Cancer Research (EACR), will focus on Gene fusions: from gene architecture evolution, cell addiction and exploring new therapeutic opportunities.

The aim of the symposium is to foster strategic collaboration among basic scientists, translational and clinical researchers to discuss diagnostic challenges and the future of new therapies. Focusing on the topic of gene fusions and oncogenic fusion in different cancer types will result in promising new insights from Symposium participants.